Haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with dalteparin

Spanish retrospective cohort study reported higher risk of bleeding with dalteparin in patients with renal insufficiency (RI) vs those with normal renal function (n=367; 17.9% vs 7.3%) and identified RI (MDRD-4 (Modification of Diet in Renal Disease) <50 mL/min) as a risk factor.

European Journal of Hospital Pharmacy